Potential uses of Probiotics in clinical practice

被引:581
作者
Reid, G
Jass, J
Sebulsky, MT
McCormick, JK
机构
[1] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON N6A 4V2, Canada
[2] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada
[3] Univ Western Ontario, Dept Surg, London, ON N6A 5C1, Canada
关键词
D O I
10.1128/CMR.16.4.658-672.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is now mounting evidence that selected probiotic strains can provide health benefits to their human hosts. Numerous clinical trials show that certain strains can improve the outcome of intestinal infections by reducing the duration of diarrhea. Further investigations have shown benefits in reducing the recurrence of urogenital infections in women, while promising studies in cancer and allergies require research into the mechanisms of activity for particular strains and better-designed trials. At present, only a small percentage of physicians either know of probiotics or understand their potential applicability to patient care. Thus, probiotics are not yet part of the clinical arsenal for prevention and treatment of disease or maintenance of health. The establishment of accepted standards and guidelines, proposed by the Food and Agriculture Organization of the United Nations and the World Health Organization, represents a key step in ensuring that reliable products with suitable, informative health claims become available. Based upon the evidence to date, future advances with single- and multiple-strain therapies are on the horizon for the management of a number of debilitating and even fatal conditions.
引用
收藏
页码:658 / +
页数:16
相关论文
共 150 条
[1]   ON THE SAFETY OF LACTIC-ACID BACTERIA FROM FOOD [J].
ADAMS, MR ;
MARTEAU, P .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1995, 27 (2-3) :263-264
[2]  
Aiba Y, 1998, AM J GASTROENTEROL, V93, P2097, DOI 10.1111/j.1572-0241.1998.00600.x
[3]   Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon [J].
Arimochi, H ;
Kinouchi, T ;
Kataoka, K ;
Kuwahara, T ;
Ohnishi, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (03) :753-757
[4]   Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) [J].
Arunachalam, K ;
Gill, HS ;
Chandra, RK .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2000, 54 (03) :263-267
[5]   PREVENTIVE EFFECT OF A LACTOBACILLUS-CASEI PREPARATION ON THE RECURRENCE OF SUPERFICIAL BLADDER-CANCER IN A DOUBLE-BLIND TRIAL [J].
ASO, Y ;
AKAZA, H ;
KOTAKE, T ;
TSUKAMOTO, T ;
IMAI, K ;
NAITO, S .
EUROPEAN UROLOGY, 1995, 27 (02) :104-109
[6]   Potential role of lactobacilli as prophylactic agents against genital pathogens [J].
Barbés, C ;
Boris, S .
AIDS PATIENT CARE AND STDS, 1999, 13 (12) :747-751
[7]   Antibiotic-associated diarrhea [J].
Bartlett, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) :334-339
[8]   Antibiotic-associated diarrhoea and Clostridium difficile in the community [J].
Beaugerie, L ;
Flahault, A ;
Barbut, F ;
Atlan, P ;
Lalande, V ;
Cousin, P ;
Cadilhac, M ;
Petit, JC .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (07) :905-912
[9]   Sexually transmitted infections and associated socio-demographic and behavioural factors in women seeking primary care suggest Madagascar's vulnerability to rapid HIV spread [J].
Behets, F ;
Andriamiadana, J ;
Rasamilalao, D ;
Ratsimbazafy, N ;
Randrianasolo, D ;
Dallabetta, G ;
Cohen, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (03) :202-211
[10]   Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood [J].
Benn, CS ;
Thorsen, P ;
Jensen, JS ;
Kjær, BB ;
Bisgaard, H ;
Andersen, M ;
Rostgaard, K ;
Björkstén, B ;
Melbye, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (01) :72-77